Dr.
Institut de Recherches Servier, Ile-de-France, France
Thierry Dorval received a B.S. degree in physic and graduated in image processing and artificial intelligence at Pierre & Marie Curie University, Paris, France. He received a Ph.D.d then joined the Institut Pasteur Korea in 2005 first as researcher in biological image analysis then as a group leader specialized in High Content Screening applied to cellular differentiation as well as toxicity prediction.
In 2012 he joined AstraZeneca, UK. His activities were about developing and advising on quantitative image and data analysis solutions in support of high content phenotypic screens in addition to cellular and tissue imaging.
In 2015 he joined Servier, France, as leader of the High Content Screening group within CPCB CentEX. He is currently still working on phenotypic approaches to improve drug discovery pipeline using high content strategies and currently lead the Data Science Lab.
Disclosure information not submitted.
Monday, February 7, 2022
1:00 PM – 2:30 PM